Finally, a mouse glioma-initiating NS cell line (IENS cells), lacking INK4A/ARF and overexpressing EGFRvIII [50], also displayed greater sensitivity to BI 2536 or J101 (Figure S6). The gene discussed is CDKN2A; the disease is central nervous system cancer.